4
Changes in Ownership
Tarsus Pharmaceuticals, Inc. Filed Acc 0001228684-26-000006
Director sold 12,500 shares at an average $62.12 ($776,495)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
LINK WILLIAM J PHD · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-15 | Sale : show line 1 in the form 10b5-1 | −10,572 | $61.97 | $655,147 | 108,714 | D |
| 2026-06-15 | Sale : show line 2 in the form 10b5-1 | −1,928 | $62.94 | $121,348 | 106,786 | D |
| Open-market sales · 12,500 sh · avg $62.12 · $776,495 | ||||||
Loading xslF345X06/wk-form4_1781727420.xml…